Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes

Experimental Eye Research

Volumn 89, Issue 1, 2009, Pages 4-15

  Klaassen, Ingeborg ^a,b   Hughes, John M ^a,b   Vogels, Ilse M C ^a,b   Schalkwijk, Casper G ^c   Van Noorden, Cornelis J F ^a,b   Schlingemann, Reinier O ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

blood brain barrier; blood retina barrier; caveolae; diabetes; diabetic retinopathy; plasmalemma vesicle associated protein; real time PCR; streptozotocin; tight junctions; vascular permeability

Indexed keywords

CAVEOLIN 1; CLAUDIN 5; MESSENGER RNA; OCCLUDIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOCYTOSIS; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERICYTE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA CAPILLARY; RETINA CELL; STREPTOZOCIN DIABETES; TIGHT JUNCTION;

ADHERENS JUNCTIONS; ANIMALS; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; CATTLE; CELLS, CULTURED; DATABASES, NUCLEIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; EYE PROTEINS; GENE EXPRESSION REGULATION; PERICYTES; RATS; RATS, WISTAR; RETINA; RNA, MESSENGER; TIGHT JUNCTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VESICULAR TRANSPORT PROTEINS;

EID: 67349236067     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.01.006     Document Type: Article

References (62)

1. Antonetti D.A., Barber A.J., Hollinger L.A., Wolpert E.B., and Gardner T.W. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 274 (1999) 23463-23467
2. Antonetti D.A., Barber A.J., Khin S., Lieth E., Tarbell J.M., and Gardner T.W. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47 (1998) 1953-1959
3. Balsamo J., Thaiboldeaux R., Swaminathan N., and Lilien J. Antibodies to the retina N-acetylgalactosaminylphosphotransferase modulate N-cadherin-mediated adhesion and uncouple the N-cadherin transferase complex from the actin-containing cytoskeleton. J. Cell Biol. 113 (1991) 429-436
4. Barber A.J., and Antonetti D.A. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Investig. Ophthalmol. Vis. Sci. 44 (2003) 5410-5416
5. Bhattacharya R., Kang-Decker N., Hughes D.A., Mukherjee P., Shah V., McNiven M.A., and Mukhopadhyay D. Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 19 (2005) 1692-1694
6. Brankin B., Campbell M., Canning P., Gardiner T.A., and Stitt A.W. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium. Exp. Eye Res. 81 (2005) 22-31
7. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., and Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
8. Cunha-Vaz J.G. Blood-retinal barriers in health and disease. Trans. Ophthalmol. Soc. U.K. 100 (1980) 337-340
9. Dai J., Vrensen G.F., and Schlingemann R.O. Blood-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus. Brain Res. 954 (2002) 311-316
10. Davidson M.K., Russ P.K., Glick G.G., Hoffman L.H., Chang M.S., and Haselton F.R. Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. Am. J. Ophthalmol. 129 (2000) 267-269
11. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5 (2004) 261-270
12. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
13. Esser S., Lampugnani M.G., Corada M., Dejana E., and Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111 (1998) 1853-1865
14. Fong D.S., Aiello L.P., Ferris III F.L., and Klein R. Diabetic retinopathy. Diabetes Care 27 (2004) 2540-2553
15. Fontijn R.D., Rohlena J., van Marle J., Pannekoek H., and Horrevoets A.J. Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier function. Eur. J. Cell Biol. 85 (2006) 1131-1144
16. Frank R.N. Diabetic retinopathy. N. Engl. J. Med. 350 (2004) 48-58
17. Funayama N., Fagotto F., McCrea P., and Gumbiner B.M. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J. Cell Biol. 128 (1995) 959-968
18. Furuse M., Sasaki H., and Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 147 (1999) 891-903
19. Gardner T.W. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans. Am. Ophthalmol. Soc. 93 (1995) 583-621
20. Gerhardt H., Liebner S., Redies C., and Wolburg H. N-cadherin expression in endothelial cells during early angiogenesis in the eye and brain of the chicken: relation to blood-retina and blood-brain barrier development. Eur. J. Neurosci. 11 (1999) 1191-1201
21. Harhaj N.S., and Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36 (2004) 1206-1237
22. Hofman P., Blaauwgeers H.G., Tolentino M.J., Adamis A.P., Nunes Cardozo B.J., Vrensen G.F., and Schlingemann R.O. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr. Eye Res. 21 (2000) 637-645
23. Hofman P., Blaauwgeers H.G., Vrensen G.F., and Schlingemann R.O. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys. Ophthalmic Res. 33 (2001) 156-162
24. Hofman P., Hoyng P., vanderWerf F., Vrensen G.F., and Schlingemann R.O. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Investig. Ophthalmol. Vis. Sci. 42 (2001) 895-901
25. Hughes J.M., Kuiper E.J., Klaassen I., Canning P., Stitt A.W., Van Bezu J., Schalkwijk C.G., Van Noorden C.J., and Schlingemann R.O. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia 50 (2007) 1089-1098
26. Kessels M.M., Dong J., Leibig W., Westermann P., and Qualmann B. Complexes of syndapin II with dynamin II promote vesicle formation at the trans-Golgi network. J. Cell Sci. 119 (2006) 1504-1516
27. Kevil C.G., Payne D.K., Mire E., and Alexander J.S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273 (1998) 15099-15103
28. Kim H., Lee T., Lee J., Ahn M., Moon C., Wie M.B., and Shin T. Immunohistochemical study of caveolin-1 and -2 in the rat retina. J. Vet. Sci. 7 (2006) 101-104
29. Kiuchi-Saishin Y., Gotoh S., Furuse M., Takasuga A., Tano Y., and Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J. Am. Soc. Nephrol. 13 (2002) 875-886
30. Kuiper E.J., Hughes J.M., Van Geest R.J., Vogels I.M.C., Goldschmeding R., Van Noorden C.J.F., Schlingemann R.O., and Klaassen I. VEGF-A induces expression of pro-fibrotic growth factor and extracellular matrix genes in the retina. Investig. Ophthalmol. Vis. Sci. 48 (2007) 4267-4276
31. Lang D.M., Lommel S., Jung M., Ankerhold R., Petrausch B., Laessing U., Wiechers M.F., Plattner H., and Stuermer C.A. Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J. Neurobiol. 37 (1998) 502-523
32. Matsunaga M., Hatta K., and Takeichi M. Role of N-cadherin cell adhesion molecules in the histogenesis of neural retina. Neuron 1 (1988) 289-295
33. Morita K., Furuse M., Fujimoto K., and Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Nat. Acad. Sci. U.S.A. 96 (1999) 511-516
34. Morita K., Sasaki H., Furuse M., and Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147 (1999) 185-194
35. Nagasawa K., Chiba H., Fujita H., Kojima T., Saito T., Endo T., and Sawada N. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J. Cell. Physiol. 208 (2006) 123-132
36. Navaratna D., McGuire P.G., Menicucci G., and Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56 (2007) 2380-2387
37. Niemela H., Elima K., Henttinen T., Irjala H., Salmi M., and Jalkanen S. Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood 106 (2005) 3405-3409
38. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., and Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003) 653-660
39. Otero K., Martinez F., Beltran A., Gonzalez D., Herrera B., Quintero G., Delgado R., and Rojas A. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem. J. 359 (2001) 567-574
40. Pascariu M., Bendayan M., and Ghitescu L. Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes. J. Histochem. Cytochem. 52 (2004) 65-76
41. Rahner C., Mitic L.L., and Anderson J.M. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120 (2001) 411-422
42. Ruiter D.J., Schlingemann R.O., Westphal J.R., Denijn M., Rietveld F.J., and De Waal R.M. Angiogenesis in wound healing and tumor metastasis. Behring Inst. Mitt. 92 (1993) 258-272
43. Russ P.K., Davidson M.K., Hoffman L.H., and Haselton F.R. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes. Investig. Ophthalmol. Vis. Sci. 39 (1998) 2479-2485
44. Schlingemann R.O., Dingjan G.M., Emeis J.J., Blok J., Warnaar S.O., and Ruiter D.J. Monoclonal antibody PAL-E specific for endothelium. Lab. Investig. 52 (1985) 71-76
45. Schlingemann R.O., Hofman P., Anderson L., Troost D., and van der Gaag R. Vascular expression of endothelial antigen PAL-E indicates absence of blood-ocular barriers in the normal eye. Ophthalmic Res. 29 (1997) 130-138
46. Schlingemann R.O., Hofman P., Klooster J., Blaauwgeers H.G., Van der Gaag R., and Vrensen G.F. Ciliary muscle capillaries have blood-tissue barrier characteristics. Exp. Eye Res. 66 (1998) 747-754
47. Schlingemann R.O., Hofman P., Vrensen G.F., and Blaauwgeers H.G. Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage. Diabetologia 42 (1999) 596-602
48. Schlingemann R.O., Rietveld F.J., Kwaspen F., van de Kerkhof P.C., de Waal R.M., and Ruiter D.J. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138 (1991) 1335-1347
49. Sherry D.M., and Heidelberger R. Distribution of proteins associated with synaptic vesicle endocytosis in the mouse and goldfish retina. J. Comp. Neurol. 484 (2005) 440-457
50. Sherry D.M., Wang M.M., and Frishman L.J. Differential distribution of vesicle associated membrane protein isoforms in the mouse retina. Mol. Vision 9 (2003) 673-688
51. Sontag J.-M., Fykse E.M., Ushkaryov Y., Liu J.-P., Robinson P.J., and Sudhof T.C. Differential expression and regulation of multiple dynamins. J. Biol. Chem. 269 (1994) 4547-4554
52. Stan R.V., Arden K.C., and Palade G.E. cDNA and protein sequence, genomic organization, and analysis of cis regulatory elements of mouse and human PLVAP genes. Genomics 72 (2001) 304-313
53. Stan R.V., Ghitescu L., Jacobson B.S., and Palade G.E. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J. Cell Biol. 145 (1999) 1189-1198
54. Tserentsoodol N., Shin B.C., Suzuki T., and Takata K. Colocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye. Histochem. Cell Biol. 110 (1998) 543-551
55. Valyi-Nagy T., Sheth V., Clement C., Tiwari V., Scanlan P., Kavouras J.H., Leach L., Guzman-Hartman G., Dermody T.S., and Shukla D. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr. Eye Res. 29 (2004) 303-309
56. Vinores S.A., and Campochiaro P.A. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition. Exp. Eye Res. 49 (1989) 495-510
57. Vinores S.A., Derevjanik N.L., Mahlow J., Berkowitz B.A., and Wilson C.A. Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol. Res. Pract. 194 (1998) 497-505
58. Vinores S.A., Van Niel E., Swerdloff J.L., and Campochiaro P.A. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium. Histochem. J. 25 (1993) 648-663
59. Wolburg H., Wolburg-Buchholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S., Duffner F., Grote E.H., Risau W., and Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105 (2003) 586-592
60. Wright T.J., Leach L., Shaw P.E., and Jones P. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp. Cell Res. 280 (2002) 159-168
61. Yao Q., Chen J., Cao H., Orth J.D., McCaffery J.M., Stan R.V., and McNiven M.A. Caveolin-1 interacts directly with dynamin-2. J. Mol. Biol. 348 (2005) 491-501
62. Yokomori H., Oda M., Yoshimura K., Nagai T., Ogi M., Nomura M., and Ishii H. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int. 23 (2003) 467-475